ECSP15007708A - NITROGEN-CONTAINING 5-MEMBER HETEROCYCLES REPLACED BY CARBOXAMIDE OR SULPHONAMIDE AS MODULATORS FOR THE ROR [GAMMA] ORPHAN NUCLEAR RECEPTOR - Google Patents

NITROGEN-CONTAINING 5-MEMBER HETEROCYCLES REPLACED BY CARBOXAMIDE OR SULPHONAMIDE AS MODULATORS FOR THE ROR [GAMMA] ORPHAN NUCLEAR RECEPTOR

Info

Publication number
ECSP15007708A
ECSP15007708A ECIEPI20157708A ECPI201507708A ECSP15007708A EC SP15007708 A ECSP15007708 A EC SP15007708A EC IEPI20157708 A ECIEPI20157708 A EC IEPI20157708A EC PI201507708 A ECPI201507708 A EC PI201507708A EC SP15007708 A ECSP15007708 A EC SP15007708A
Authority
EC
Ecuador
Prior art keywords
gamma
ror
modulators
nuclear receptor
carboxamide
Prior art date
Application number
ECIEPI20157708A
Other languages
Spanish (es)
Inventor
Christoph Steeneck
Gerald Kleymann
Olaf Kinzel
Christian Gege
Thomas Hoffmann
Original Assignee
Phenex Pharmaceuticals Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phenex Pharmaceuticals Ag filed Critical Phenex Pharmaceuticals Ag
Publication of ECSP15007708A publication Critical patent/ECSP15007708A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La invención provee moduladores para el receptor nuclear huérfano ROR[gamma] y métodos para tratar enfermedades mediadas por ROR[gamma] mediante la administración de estos nuevos moduladores de ROR[gamma] a un humano o mamífero que los necesita. Específicamente, la presente invención provee compuestos cíclicos que contienen carboxamida de Fórmula (1) a Fórmula (5) y los enantiómeros, diastereómeros, tautómeros, N-óxidos, solvatos y sales farmacéuticamente aceptables de los mismos.The invention provides modulators for the orphan nuclear receptor ROR [gamma] and methods for treating ROR [gamma] mediated diseases by administering these novel ROR [gamma] modulators to a human or mammal in need thereof. Specifically, the present invention provides cyclic carboxamide-containing compounds of Formula (1) to Formula (5) and the enantiomers, diastereomers, tautomers, N-oxides, solvates, and pharmaceutically acceptable salts thereof.

ECIEPI20157708A 2012-08-09 2015-03-02 NITROGEN-CONTAINING 5-MEMBER HETEROCYCLES REPLACED BY CARBOXAMIDE OR SULPHONAMIDE AS MODULATORS FOR THE ROR [GAMMA] ORPHAN NUCLEAR RECEPTOR ECSP15007708A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261681296P 2012-08-09 2012-08-09
EP12005789 2012-08-09

Publications (1)

Publication Number Publication Date
ECSP15007708A true ECSP15007708A (en) 2015-12-31

Family

ID=70289070

Family Applications (1)

Application Number Title Priority Date Filing Date
ECIEPI20157708A ECSP15007708A (en) 2012-08-09 2015-03-02 NITROGEN-CONTAINING 5-MEMBER HETEROCYCLES REPLACED BY CARBOXAMIDE OR SULPHONAMIDE AS MODULATORS FOR THE ROR [GAMMA] ORPHAN NUCLEAR RECEPTOR

Country Status (2)

Country Link
EC (1) ECSP15007708A (en)
NI (1) NI201500016A (en)

Also Published As

Publication number Publication date
NI201500016A (en) 2015-09-21

Similar Documents

Publication Publication Date Title
CO7310529A2 (en) 5-membered nitrogen heterocycles containing carboxamide or sulfonamide substituted as modulators for the orphan nuclear receptor rory
NZ702539A (en) Carboxamide or sulfonamide substituted thiazoles and related derivatives as modulators for the orphan nuclear receptor ror[gamma]
UY35675A (en) SUBSTITUTED DERIVATIVES OF QUINAZOLIN-4-ONA
ECSP13012611A (en) PIRAZOL-AMINOPIRIMIDINE DERIVATIVES AS MODULATORS OF THE LRRK2
CR20150474A (en) TETRACYCLIC BROMODOMINES INHIBITORS
NI201500077A (en) NOVELTY BENZIMIDAZOLE DERIVATIVES AS EP4 ANTAGONISTS
UY35142A (en) DERIVATIVES OF TRIAZOLOPIRAZINS AS INHIBITORS OF BRD4
UY35485A (en) HETEROCYCLIC COMPOUNDS AND USES OF THE SAME
CO7131360A2 (en) Novel substituted cyclic n-pyridinyl amides as kinase inhibitors
NI201200016A (en) PYRIDINE AND PIRAZINE DERIVATIVES AS PROTEIN KINASE MODULATORS
CR20120591A (en) AMINOPIRIMIDINE DERIVATIVES AS MODULATORS OF THE LRRK2
CL2017000432A1 (en) Cathepsin c spirocyclic inhibitors
UY33497A (en) DERIVATIVES OF ESPIRO-PIPERIDINE AS S1P MODULATORS
NI201500050A (en) BENZAMIDES
UY35419A (en) PIRROLO KINASA CDK9 INHIBITORS (2,3- B) PIRIDINE
UY35906A (en) NEWS DERIVED FROM BENCIMIDAZOL AS LIGANDOS OF EP4
ECSP13012893A (en) ASYMMETRIC UREAS AND MEDICAL USES OF THE SAME
ECSP14002542A (en) NOVEL 2HINDAZOLES AS EP2 RECEPTOR ANTAGONISTS
ECSP14013156A (en) TETRAHYDROCHINOLINES CONDENSED WITH CYCLOALKYL AS MODULATORS OF CRTH2 RECEPTORS.
ECSP16074482A (en) CYCLOPENTANES, TETRAHYDROFURANS AND PYRROLIDINES SUBSTITUTED AS OREXIN RECEPTOR ANTAGONISTS
PE20150674A1 (en) AZAHETEROCICLES AS INHIBITORS OF BIR2 AND / OR BIR3
UY37507A (en) ROR GAMMA MODULATORS (ROR¿)
ECSP15007708A (en) NITROGEN-CONTAINING 5-MEMBER HETEROCYCLES REPLACED BY CARBOXAMIDE OR SULPHONAMIDE AS MODULATORS FOR THE ROR [GAMMA] ORPHAN NUCLEAR RECEPTOR
ECSP16094286A (en) COMPOUNDS, PHARMACEUTICAL COMPOSITION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES
ECSP14033496A (en) THIAZOLS SUBSTITUTED BY CARBOXAMIDE OR SULFONAMIDE AND RELATED DERIVATIVES AS MODULATORS FOR THE ROR [GAMMA] ORPHAN NUCLEAR RECEPTOR